Numerous agents increase gastric mucosal resistance against intralumin
al ulcerogens. Although the precise mechanisms of gastroprotection are
uncertain, various endogenous mediators involved in gastroprotective
effects have been characterized. As prostaglandins exert potent protec
tive effects and inhibition of prostaglandin formation abolishes ''ada
ptive gastroprotection,'' they have been proposed as key mediators in
mucosal defense. This paper reviews the role of endogenous prostagland
ins showing striking differences between different forms of gastroprot
ection. Thus, whereas the protective effect of the antiulcer drug reba
mipide involves prostaglandins as essential mediators, the protection
conferred by the antacid hydrotalcit is prostaglandin-independent. Fur
thermore, gastroprotection can occur even when mucosal prostaglandin g
eneration is suppressed. This phenomenon has been observed with some n
onsteroidal antiinflammatory drugs, agents that modulate sulfhydryls a
nd certain metals. Recent data suggest that both cyclooxygenase-1- and
cyclooxygenase-2-derived prostaglandins can increase mucosal resistan
ce. The precise role of constitutive and inducible forms of cyclooxyge
nase in gastroprotection, however, remains to be established.